全球健康与长寿每日简报Global Health & Longevity Daily Briefing

中中山大学赵文婧团队与深圳湾实验室唐啸宇团队在《自然》发表研究：肠道共生菌单形拟杆菌等可产生天然脂肪酸十五酸，作用于胆固醇合成关键酶HMGCR（他汀类药物靶点），减少胆固醇合成并促进肝脏清除坏胆固醇。小鼠模型中补充十五酸改善血脂、减少动脉斑块，人群样本亦显示血脂异常者十五酸水平存在差异。

ENIn a Nature study, teams from Sun Yat-sen University and Shenzhen Bay Laboratory showed that gut commensals such as Bacteroides uniformis produce the natural fatty acid pentadecanoic acid, which targets HMGCR — the same enzyme hit by statins — reducing cholesterol synthesis and promoting hepatic clearance of LDL. In atherosclerotic mice, pentadecanoic acid supplementation improved blood lipids and reduced arterial plaques, with consistent differences seen in human cohorts.

中热心肠日报第3753期头条：香港中文大学黄秀娟、徐之璐团队发表于GUT的研究揭示了肠道菌群与肌少症的关联在糖尿病与非糖尿病人群中存在显著差异，提示在代谢病背景下解读菌群-肌肉轴信号必须分层分析，为肌少症与糖尿病共病的精准肠菌干预提供了人群证据。

ENHeadline of Mr Gut Daily issue 3753: a GUT study by Huang Xiu-juan and Xu Zhilu's teams at the Chinese University of Hong Kong shows that the association between gut microbes and sarcopenia differs markedly between people with and without diabetes, implying that gut–muscle axis signals must be interpreted in strata under metabolic disease — population evidence for precision microbiome interventions in comorbid sarcopenia and diabetes.

中热心肠日报第3751期头条：北京朝阳医院刘心娟团队聚焦肠道菌群表型可塑性，通过追踪菌群动态变化特征来预测溃疡性结肠炎的疾病进程。该研究提示静态的菌群组成之外，菌群的功能状态与动态波动可能成为功能性胃肠病风险评估的新维度，为功能医学视角下的肠病早期预警提供工具。

ENHeadline of Mr Gut Daily issue 3751: Liu Xinjuan's team at Beijing Chaoyang Hospital focused on microbiome phenotypic plasticity, tracking dynamic microbial signatures to predict the course of ulcerative colitis. Beyond static composition, functional states and temporal fluctuations of the microbiome may become a new dimension for gut-disease risk assessment, supporting early warning from a functional-medicine perspective.

中香港中文大学李中、段崇智团队在Science Advances发表研究，利用微流控芯片构建微生物-肠-软骨轴模型，解码益生菌维持关节稳态、改善骨关节炎的机制。该工作为肠-关节远程对话提供了可视化实验平台，也为骨关节炎的微生态干预策略提供了机制层面的功能医学证据。

ENIn Science Advances, Jun Liu, Duo Chan-cheung and Li Zhong's teams at the Chinese University of Hong Kong built a microbe–gut–cartilage axis-on-a-chip to decode how probiotics maintain joint homeostasis and ameliorate osteoarthritis. The platform visualizes long-range gut–joint crosstalk, offering mechanistic functional-medicine evidence for microbiome-based osteoarthritis interventions.

中Rubedo Life Sciences公布其抗衰候选药物RLS-1496的1b期临床数据：局部治疗后光老化皮肤的表观遗传年龄平均减少2.1岁，同时循环炎症标志物下降。这是衰老细胞靶向疗法在人体皮肤层面交出的首个表观遗传学证据，展示了局部senolytic干预在皮肤抗衰领域的转化潜力。

ENRubedo Life Sciences reported Phase 1b data for its anti-aging candidate RLS-1496: topical treatment reduced the epigenetic age of photoaged skin by an average of 2.1 years and lowered circulating inflammatory markers. It is the first epigenetic evidence in human skin for a senescence-targeted therapy, highlighting the translational potential of local senolytic intervention for skin rejuvenation.

中斯洛文尼亚卢布尔雅那大学团队首次整合144个基因与56种早衰症，绘制出首张人类早衰基因表型网络图。研究发现DNA修复是所有早衰机制的核心（P<1.0×10⁻¹⁶），表明修复基因损伤不仅能对抗罕见早衰综合征，更可能是延缓人类正常生理性衰老的关键突破口，为长寿医学锚定了新的干预方向。

ENA University of Ljubljana team integrated 144 genes and 56 progeroid disorders to draw the first human progeria gene–phenotype network. DNA repair emerged as the core of all premature-aging mechanisms (P < 1.0×10⁻¹⁶), suggesting that repairing genetic damage may be key not only against rare progeria but also to delaying normal physiological aging — anchoring a new interventional direction for longevity medicine.

中发表于Frontiers in Medicine的研究对比了25-35岁与70-80岁人群的脑脊液，首次绘制人类大脑微环境的代谢漂移图谱：脂质、氨基酸等33种代谢物随年龄显著改变，肌酸等升高而特定抗氧化与营养成分下降。这为评估大脑衰老程度提供了分子参照系，也为通过调节脑脊液代谢实现大脑年轻化提示了潜在干预靶点。

ENA Frontiers in Medicine study compared cerebrospinal fluid from people aged 25–35 and 70–80, mapping for the first time the metabolic drift of the brain's microenvironment: 33 metabolites including lipids and amino acids changed significantly with age, with creatine rising while certain antioxidants and nutrients declined. The work offers a molecular reference frame for brain-aging assessment and hints at CSF-metabolite targets for rejuvenation.

中阿布扎比公共卫生中心与可穿戴设备公司Ultrahuman达成两年合作，开发并验证生物学健康年龄模型。该项目将临床生物标志物与可穿戴设备数据相结合，探索将衰老评估大规模引入公共卫生与早期干预体系的可行性，是长寿医学从个体化服务走向人群健康管理的重要实践案例。

ENThe Abu Dhabi Public Health Center has signed a two-year partnership with wearables company Ultrahuman to develop and validate a biological health-age model. Combining clinical biomarkers with wearable data, the project explores bringing aging assessment at scale into public health and early intervention — a landmark case of longevity medicine moving from individual services to population-level health management.

中热心肠日报解读Nature Reviews综述：精准营养正依靠基因组、代谢组、肠道微生物组与CGM等可穿戴数据的深度表型融合实现个体化。研究表明特定肠型可预测餐后血糖反应与减重敏感性，GluFormer等基础模型能模拟膳食对血糖轨迹的影响；个性化饮食干预临床试验已证实可提升饮食质量评分并降低心血管代谢风险指标。

ENMr Gut Daily reviews a Nature Reviews paper: precision nutrition is achieving personalization through deep phenotyping that fuses genomics, metabolomics, the gut microbiome and wearable data such as CGM. Specific enterotypes predict postprandial glycemic responses and weight-loss sensitivity, foundation models like GluFormer can simulate dietary impacts on glucose trajectories, and personalized-diet RCTs have improved diet quality scores and cardiometabolic risk markers.

中内蒙古农业大学张文羿、张猛团队在Advanced Science发表食品级菌群靶向干预研究：大学生耐力运动员的生理指标与肠道生态系统对干预的响应呈现显著的性别与时间差异。该成果提示运动营养与菌群干预方案应按性别分层设计，为运动人群的精准营养补给了新的循证依据。

ENIn Advanced Science, Zhang Wenyi and Zhang Meng's teams at Inner Mongolia Agricultural University report a food-grade microbiome-targeted intervention in collegiate endurance athletes: physiological and gut-ecosystem responses showed pronounced sex- and time-resolved differences. The findings argue for sex-stratified design of sports nutrition and microbiome interventions, adding new evidence for precision nutrition in athletes.

中由广东省农业科学院牵头的2026食品精准营养与智能制造科技创新论坛10日至11日在广州举办。朱蓓薇院士分享精准体重管理与AI健康管理新范式，吴清平、谢明勇、金征宇等院士分别就功能微生物、功能食品与粮食精深加工作报告；论坛还签订共建精准营养与功能食品研究院等多项产学研合作协议。

ENThe 2026 Forum on Food Precision Nutrition and Intelligent Manufacturing, led by the Guangdong Academy of Agricultural Sciences, was held in Guangzhou on October 10–11. Academician Zhu Beiwei presented precision weight management and AI-enabled health management, while academicians Wu Qingping, Xie Mingyong and Jin Zhengyu covered functional microbes, functional foods and grain processing; multiple industry–academia agreements, including a precision nutrition research institute, were signed.

中热心肠日报第3750期头条：浙江大学付爱坤团队在iMeta发表研究，发现肠道病毒组（噬菌体）可在低蛋白饮食条件下充当营养缓冲器，通过调控菌群代谢缓冲宿主的蛋白质营养压力。该发现拓展了病毒组在营养代谢中的功能认知，为低蛋白饮食人群与特殊营养干预场景的精准方案设计提供了新视角。

ENHeadline of Mr Gut Daily issue 3750: Fu Aikun's team at Zhejiang University reported in iMeta that the gut virome (phages) can act as a nutrient buffer under low-protein diets, modulating microbial metabolism to buffer the host's protein-nutrition stress. The finding extends functional understanding of the virome in nutrition metabolism and informs precision strategies for low-protein and special dietary scenarios.

中美国法院下令冻结仿冒长寿补剂品牌Timeline的欺诈性网站，标志着长寿营养补剂领域的品牌保护与消费者安全行动升级。随着NMN等长寿补剂市场快速膨胀，仿冒产品风险同步上升，此案为行业敲响警钟：购买渠道与正品验证正在成为长寿补剂消费不可忽视的环节。

ENA US court has ordered the freeze of fraudulent copycat websites impersonating longevity supplement brand Timeline, marking an escalation in brand-protection and consumer-safety actions in the longevity supplements space. As markets for NMN-type products expand rapidly, counterfeit risk rises too — the case underscores that purchase channels and authenticity verification now matter for supplement consumers.

中针对睡眠补剂市场的持续升温，NutraIngredients系统梳理了镁与睡眠关系的科学证据：现有随机对照试验整体规模小、异质性高，镁在特定缺镁人群中或可改善睡眠质量，但对一般人群的助眠证据仍有限。文章提醒品牌与消费者理性看待营销宣称，剂量、形式与基线营养状态是解读疗效的关键变量。

ENAs sleep supplements heat up, NutraIngredients reviewed the evidence on magnesium and sleep: existing RCTs are small and heterogeneous, magnesium may improve sleep quality in deficient individuals, but evidence for the general population remains limited. The piece urges brands and consumers to treat marketing claims with caution — dose, form and baseline nutritional status are key variables.

中NutraIngredients报道新研究提示，特定益生菌菌株可能支持运动耐力表现，为运动营养补剂中的益生菌赛道再添证据。研究者关注菌株对能量代谢与肠道屏障的作用通路；业内指出，从单一菌株阳性结果到可标注的运动表现声称，仍需更大规模可重复试验与监管认可，品牌布局宜循证先行。

ENNutraIngredients reports that a specific probiotic strain may support exercise endurance, adding evidence to the probiotic track within sports nutrition. Researchers focus on pathways linking the strain to energy metabolism and gut barrier function; the industry notes that moving from a single-strain positive result to labelable performance claims will require larger, reproducible trials and regulatory acceptance.

中新西兰正就天然健康产品监管规则调整公开征询意见，核心议题包括健康声称的审批框架与产品上市前准入机制。若新规落地，天然健康产品与膳食补剂在宣称 substantiation、上市路径与合规成本上都将面临重构，对出口新西兰市场的亚洲补剂企业尤其值得关注。

ENNew Zealand has opened public consultation on changes to natural health product rules, centering on the approval framework for health claims and pre-market entry mechanisms. If adopted, the rules would reshape claim substantiation, market pathways and compliance costs for natural health products and supplements — of particular note for Asian supplement exporters targeting the New Zealand market.

中诚益生物宣布其每日一次口服小分子GLP-1受体激动剂elecoglipron（AZD5004/ECC5004）全球III期临床在中国完成首例患者入组。项目涵盖肥胖/超重、2型糖尿病及心衰、慢性肾病结局研究，与阿斯利康合作推进大中华区开发。口服小分子GLP-1竞速加剧，肥胖慢病管理的用药可及性格局或被改写。

ENEccogene announced that its once-daily oral small-molecule GLP-1 receptor agonist elecoglipron (AZD5004/ECC5004) dosed its first patient in China within the global Phase 3 program. The project spans obesity/overweight, type 2 diabetes, and outcome studies in heart failure and chronic kidney disease, developed with AstraZeneca in Greater China. The oral GLP-1 race is intensifying and may reshape access in obesity and cardiometabolic management.

中Viking Therapeutics宣布启动口服GLP-1/GIP双靶点激动剂VK2735的SUNRISE III期临床项目，含两项研究、各计划入组560人，评估每日一次口服给药68周的减重疗效与安全性。口服双靶点制剂若成功，将为肥胖长期管理提供注射之外的依从性选项，与皮下制剂VANQUISH项目形成组合布局。

ENViking Therapeutics initiated the SUNRISE Phase 3 program for oral dual GLP-1/GIP agonist VK2735, comprising two studies of 560 adults each evaluating once-daily oral dosing over 68 weeks for weight loss and safety. If successful, the oral dual agonist would offer a convenient alternative to injections for long-term obesity management, complementing the subcutaneous VANQUISH program.

中发表于Obesity Sciences & Practices的研究跟踪39名停用GLP-1不久的减重者四个月：常规护理组体重回升约10.75%，而使用数字健康App组与接受医学定制餐（MTM）组分别仅回升3.6%和3.58%。结果提示停药后的体重维持需要结构化营养与行为支持，这对GLP-1时代的安全停药与长期健康管理具有直接指导意义。

ENA study in Obesity Sciences & Practices followed 39 adults who had recently stopped GLP-1 therapy for four months: usual care regained about 10.75% of body weight, while a digital wellness app group and a medically tailored meals (MTM) group regained only 3.6% and 3.58%. The results show structured nutrition and behavioral support are key to weight maintenance after discontinuation — directly relevant to safe deprescribing in the GLP-1 era.

中中国生产力学会正式公布《科学抗衰食物营养指导规范》团体标准，由江南大学等25家单位、42位专家历时近一年编制。新西兰品牌MitoQ的核心成分Mitoquinol首次作为线粒体靶向抗氧化剂纳入标准文本，维生素C、花青素、岩藻黄素等亦被收录。该团标为抗衰饮食指导与口服功能性成分应用确立了可追溯的行业参照。

ENThe China Productivity Science Society released the group standard 'Guidelines for Science-Based Anti-Aging Food Nutrition,' developed over nearly a year by 25 institutions including Jiangnan University and 42 experts. Mitoquinol, the core ingredient of New Zealand brand MitoQ, was included for the first time as a mitochondria-targeted antioxidant, alongside vitamins C/E, anthocyanins and fucoxanthin — creating a traceable industry reference for anti-aging dietary guidance.